Ocular Therapeutix, Inc Income Statement

Income Statement Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 0.01M-0.44M0.77M1.75M1.89M1.92M1.99M4.23M17.40M43.52M51.49M58.44M63.72M
Gross Profit -0.65M-0.44M-1.21M-2.10M-4.81M-15.08M-2.95M-20.26M-9.21M8.33M11.57M17.89M22.13M
Operating items
Research & Development 11.54M10.52M18.88M26.61M27.07M30.88M36.91M41.09M28.69M50.08M53.46M61.05M127.64M
Selling, General & Administrative 1.48M1.76M6.91M9.16M11.00M15.51M18.79M22.12M22.86M31.88M32.22M33.94M60.65M
Other Operating Expenses 0.66M0.62M2.07M4.17M7.14M17.46M5.41M26.82M28.70M39.60M44.46M45.83M47.22M
Operating Expenses 13.68M12.90M27.87M39.95M45.21M63.85M61.11M90.03M80.25M121.56M130.15M140.82M235.50M
Operating Income -13.67M-12.90M-27.09M-38.20M-43.33M-61.92M-59.12M-85.80M-62.85M-78.04M-78.65M-82.38M-171.78M
EBIT -13.67M-12.90M-27.09M-38.20M-43.33M-61.92M-59.12M-85.80M-62.85M-78.04M-78.65M-82.38M-171.78M
Non-operating items
Interest & Investment Income 0.00M0.01M0.01M0.17M0.30M0.42M0.88M1.23M0.17M0.03M0.80M3.98M20.28M
Other Non Operating Income -0.05M0.01M-0.44M0.01M-0.00M0.01M4.31M-86.19M0.00M-0.00M14.19M-27.95M
Non Operating Income -0.42M-0.41M-1.55M-1.55M-1.38M-1.46M-0.86M-0.57M-92.79M71.48M7.62M1.65M-21.73M
Net income details
EBT -14.04M-13.33M-28.21M-39.76M-44.70M-63.39M-59.98M-90.67M-69.45M-84.67M-84.88M-89.74M-165.08M
Profit After Tax -14.09M-13.32M-28.65M-39.75M-44.70M-63.39M-59.98M-86.37M-155.64M-6.55M-71.04M-80.74M-193.51M
Income from Continuing Operations -14.04M-13.33M-28.21M-39.76M-44.70M-63.39M-59.98M-90.67M-69.45M-84.67M-84.88M-89.74M-165.08M
Consolidated Net Income -14.04M-13.33M-28.21M-39.76M-44.70M-63.39M-59.98M-90.67M-69.45M-84.67M-84.88M-89.74M-165.08M
Income towards Parent Company -14.04M-13.33M-28.21M-39.76M-44.70M-63.39M-59.98M-90.67M-69.45M-84.67M-84.88M-89.74M-165.08M
Preferred Dividend Payments 0.04M0.03M0.01M
Net Income towards Common Stockholders -14.13M-13.34M-28.66M-39.75M-44.70M-63.39M-59.98M-90.67M-69.45M-84.67M-84.88M-89.74M-165.08M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 21.32M24.73M28.76M29.44M41.10M48.08M71.39M76.61M77.51M79.42M157.22M
EBITDA -13.67M-13.32M-28.65M-39.82M-44.64M-63.38M-59.98M-86.37M-62.85M-78.04M-78.65M-82.38M-171.78M
Shares Outstanding 2.56M2.68M21.33M24.75M25.02M29.66M41.52M50.33M76.00M76.73M77.20M114.96M157.75M